Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis

Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by structural damage to the lung parenchyma, excessive deposition of extracellular matrix (ECM), and irreversible decline in lung function. Current pharmacological treatments cannot effectively reverse fibrosis, highlightin...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yingxu Wu, Hao Yan, Pin Li, Yongming Liu, Jiapeng Leng, Yuwei Cui, Xiaodong Lv, Lijian Pang, Ningzi Zang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2026-04-01
Colección:	Frontiers in Medicine
Materias:	gut microbiome gut microbiota gut-lung axis microbial metabolites pulmonary fibrosis
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1817835/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!